(5R,5aR,8aR,9R)-9-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5-(3,4,5-trimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one; (5R,5aR,8aR,9R)-9-(?-D-Glucopyranosyloxy)-5,8,8a,9-tetrahydro-5-(3,4,5-trimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; Podophyllotoxin, ?-D-glucopyranoside; NSC 163024; Podophyllotoxin 1-O-?-D-Glycoside; Podophyllotoxin 3-?-D-Glucopyranoside; Podophyllotoxin 4-O-Glucoside; Podophyllotoxin 7'-O-?-D-Glucopyranoside; Podophyllotoxin ?-D-Glucoside; Podophyllotoxin-4-O-?-D-Glucopyranoside
Podophyllotoxin 4-O-Glucoside is a fully characterized chemical compound used as a reference standard of API Podophyllotoxin. The standard offered is compliant with regulatory guidelines. Podophyllotoxin 4-O-Glucoside is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 16481-54-2
